Abstract
According to psychotherapy outcome literature, treatments for major depressive disorder (MDD) yield impressive results. Study after study demonstrates the efficacy of brief, evidence-based interventions for depressed individuals. Nevertheless, MDD continues to exact a devastating toll on modern society. The World Health Organization has identified it as the leading cause of disability worldwide. This reality is surprising given the implications from the academic literature. A historical analysis of MDD treatment suggests that most people with MDD experienced complete remission and enhanced outcomes when long-term, psychodynamically influenced treatments prevailed. An analysis of the system that perpetuates the brief intervention model for MDD, managed care, is discussed. This analysis is followed by a case study that illustrates the harm managed care can do to patients with MDD who are not permitted treatment of longer duration. Implications and recommendations for psychologists to intervene at the micro and macro levels are discussed.
Similar content being viewed by others
References
Altman, N. (2004). History repeats itself in transference-countertransference. Psychoanalytic Dialogues, 14(6), 807–815. doi:10.1080/10481881409348807.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th edn.). Washington, DC: American Psychiatric Association.
APA Presidential Task Force on Evidence-Based Practice US (2006). Evidence-based practice in psychology. American Psychologist, 61(4), 271–285.
Baumeister, A. A., & Hawkins, M. F. (2005). Continuity and discontinuity in the historical development of modern psychopharmacology. Journal of the History of the Neurosciences, 14(3), 199–209. doi:10.1080/096470490512562.
Baxter, A. J., Scott, K. M., Ferrari, A. J., Norman, R. E., Vos, T., & Whiteford, H. A. (2014). Challenging the myth of an ‘epidemic’ of common mental disorders: Trends in the global prevalence of anxiety and depression between 1990 and 2010. Depression and Anxiety, 31(6), 506–516. doi:10.1002/da.22230.
Bolen, R. M., & Hall, J. C. (2007). Managed care and evidence based practice: The untold story. Journal of Social Work Education, 43(3), 463–481.
Broskowski, A. (1991). Current mental health care environments: Why managed care is necessary. Professional Psychology: Research and Practice, 22(1), 6–14. doi:10.1037/0735-7028.22.1.6.
Burnham, J. C. (1978). Influence of psychoanalysis upon American culture. In J. M. Quen & E. T. Carlson (Eds.), American Psychoanalysis: Origins and Development (pp. 52–73). New York: Brunner/Mazel.
Canada’s Health Care System. (2016). In canada.ca. Retrieved June 23, 2017, from https://www.canada.ca/en/health-canada/services/canada-health-care-system.html.
Cantor, D. W., & Fuentes, M. A. (2008). Psychology’s response to managed care. Professional Psychology: Research and Practice, 39(6), 638–645. doi:10.1037/0735-7028.39.6.638.
Cohen, J., Marecek, J., & Gillham, J. (2006). Is three a crowd? Clients, clinicians, and managed care. American Journal of Orthopsychiatry, 76(2), 251–259. doi:10.1037/0002-9432.76.2.251.
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013). A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry/La Revue Canadienne De Psychiatrie, 58(7), 376–385.
de Maat, S., Philipszoon, F., Schoevers, R., Dekker, J., & De Jonghe, F. (2007). Costs and benefits of long-term psychoanalytic therapy: Changes in health care use and work impairment. Harvard Review of Psychiatry, 15(6), 289–300. doi:10.1080/10673220701811654.
Depression. (2017). In World Health Organization. Retrieved May 25, 2017, from http://www.who.int/mediacentre/factsheets/fs369/en/.
Fonagy, P., Rost, F., Carlyle, J., McPherson, S., Thomas, R., Pasco Fearon, R. M., Goldberg, D., & Taylor, D. (2015). Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: The Tavistock Adult Depression Study (TADS) [Electronic version]. World Psychiatry, 14(3), 312–321.
Furukawa, T. A., Cipriani, A., Atkinson, L. Z., Leucht, S., Ogawa, Y., Takeshima, N., Hayasaka, Y., Chaimani, A., & Salanti, G. (2016). Placebo response rates in antidepressant trials: A systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry, 3(11), 1059–1066. doi:10.1016/S2215-0366(16)30307-8.
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry, 62(10), 1097–1106. doi:10.1001/archpsyc.62.10.1097.
Henriques, G. (2017). Twenty billion fails to “move the needle” on mental illness. In Psychology Today. Retrieved July 24, 2017, from https://www.psychologytoday.com/blog/theory-knowledge/201705/twenty-billion-fails-move-the-needle-mental-illness.
Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427–440. doi:10.1007/s10608-012-9476-1.
Johnsen, T. J., & Friborg, O. (2015). The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: A meta-analysis. Psychological Bulletin, 141(4), 747–768. doi:10.1037/bul0000015.
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017). Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries. World Psychiatry, 16(1), 90–99.
National Institutes of Mental Health. (2010). Just over half of Americans diagnosed with major depression receive care. Retrieved from http://www.nimh.nih.gov/news/science-news/2010/just-over-half-of-americans-diagnosed-with-major-depression-receive-care.shtml.
Knekt, P., Lindfors, O., Härkänen, T., Välikoski, M., Virtala, E., Laaksonen, M. A., Marttunen, M., Kaipainen, M., & Renlund, C. (2008). Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up. Psychological Medicine, 38(5), 689–703. doi:10.1017/S003329170700164X.
Leichsenring, F., & Rabung, S. (2011). Long term psychodynamic psychotherapy in complex mental disorders: Update of a meta-analysis. British Journal of Psychiatry, 199(1), 15–22.
Lewis-Fernández, R., Rotheram-Borus, M. J., Betts, V. T., Greenman, L., Essock, S. M., Escobar, J. I., Barch, D., Hogan, M. F., Arean, P. A., Druss, B. G., DiClemente, R. J., McGlashan, T. H., Jeste, D. V., Proctor, E. K., Ruiz, P., Rush, A. J., Canino, G. J., Bell, C. C., Henry, R., & Iversen, P. (2016). Rethinking funding priorities in mental health research. British Journal of Psychiatry, 208(6), 507–509. doi:10.1192/bjp.bp.115.179895.
Lindfors, O., Knekt, P., Heinonen, E., Härkänen, T., & Virtala, E. (2015). The effectiveness of short- and long-term psychotherapy on personality functioning during a 5-year follow-up. Journal of Affective Disorders, 173, 31–38. doi:10.1016/j.jad.2014.10.039.
Lopez-Munoz, F., & Alamo, C. (2009). Monoaminergic neurotransmission: The history of the discovery of antidepressants from the 1950s until today. Current Pharmaceutical Design, 15(14), 1563–1586.
Pilgrim, D. (2011). The hegemony of cognitive-behaviour therapy in modern mental health care. Health Sociology Review, 20(2), 120–132. doi:10.5172/hesr.2011.20.2.120.
Plakun, E. (2017). Psychotherapy, parity, and ethical utilization management. Journal of Psychiatric Practice, 23(1), 49–52.
Sanchez, L. M., & Turner, S. M. (2003). Practicing psychology in the era of managed care: Implications for practice and training. American Psychologist, 58(2), 116–129. doi:10.1037/0003-066X.58.2.116.
Toffler, A. (1970). Future shock (pp. 56–57). New York: Bantam Books.
Wampold, B. E., Flückiger, C., Del Re, A. C., Yulish, N. E., Frost, N. D., Pace, B. T., Goldberg, S. B., Miller, S. D., Baardseth, T. P., Laska, K. M., & Hilsenroth, M. J. (2017). In pursuit of truth: A critical examination of meta-analyses of cognitive behavior therapy. Psychotherapy Research, 27(1), 14–32. doi:10.1080/10503307.2016.1249433.
Wheelock, I. (2000). The value of a psychodynamic approach in a managed care setting. American Journal of Psychotherapy, 54(2), 204–215.
Whitaker, R. B. (2012). Anatomy of an epidemic: History, science, and the case against psychiatric drugs. In N. A. Cummings & W. O’Donohue (Eds.), Restoring psychotherapy as the first line intervention in behavioral care (pp. 179–222). Dryden, NY: Ithaca Press.
Wright, T., Simpson-Young, V., & Lennings, C. (2012). Therapeutic process in the context of third party determined time limits. Clinical Psychologist, 16(2), 82–92. doi:10.1111/j.1742-9552.2012.00043.x.
Zimmermann, J., Löffler-Stastka, H., Huber, D., Klug, G., Alhabbo, S., Bock, A., & Benecke, C. (2015). Is it all about the higher dose? Why psychoanalytic therapy is an effective treatment for major depression. Clinical Psychology and Psychotherapy, 22(6), 469–487. doi:10.1002/cpp.1917.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Clark, A., Goodman, G. & Petitti, C. The Persistent Case of Major Depression: An Argument for Long-Term Treatment. J Contemp Psychother 48, 33–40 (2018). https://doi.org/10.1007/s10879-017-9369-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10879-017-9369-4